STEK
Stemtech Corp
Key Financials
Gross Profit
$3.7M
↓ 4.9%
Net Income
$-3769566
↑ 30.6%
Operating Income
$-2386427
↑ 43.5%
Revenue
$5.1M
↑ 2.7%
Total Assets
$3.8M
↑ 2.7%
Total Liabilities
$9.0M
↑ 39.4%
EPS (Diluted)
$-0.03
↑ 57.1%
Cash & Equivalents
$132487.00
↓ 84.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| NT 10-K | 3/31/2026 | View on SEC |
| 10-Q | 11/19/2025 | View on SEC |
| NT 10-Q | 11/14/2025 | View on SEC |
| 10-Q | 8/19/2025 | View on SEC |
| NT 10-Q | 8/14/2025 | View on SEC |
| 10-Q | 7/17/2025 | View on SEC |
| 10-K | 6/30/2025 | View on SEC |
| 4 | 6/27/2025 | View on SEC |
| NT 10-Q/A | 5/15/2025 | View on SEC |
| NT 10-Q | 5/15/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | STEK |
| Company Name | Stemtech Corp |
| CIK | 1511820 |
| Sector | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 5122 |
| SIC Description | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (954) 715-6000 |